<DOC>
	<DOCNO>NCT01484210</DOCNO>
	<brief_summary>The aim study establish therapeutic equivalence test ( Fluticasone/Salmeterol administer Elpenhaler® , Rolenium® ) reference formulation ( Seretide® , administer Diskus® ) , contain 500/50μg Fluticasone/Salmeterol combination . The study conduct randomize , double-blind , double-dummy , 2x2 crossover fashion .</brief_summary>
	<brief_title>Single Dose Study Fluticasone/Salmeterol ( 500/50 μg ) Administered With Elpenhaler® Versus Diskus®</brief_title>
	<detailed_description>In case inhaled product , possible follow classic scheme , base similarity plasma concentration-time behavior parent drug assess bioequivalence . For reason , pharmacodynamic study design order ass therapeutic equivalence new formulation Fluticasone/Salmeterol innovative one . The test reference Fluticasone/Salmeterol formulation compare term bronchodilator effect lung function . Forced Expiratory Volume 1 second ( FEV1 ) primary efficacy measure measure way similar time-dependent increase pulmonary function demonstrate Fluticasone/Salmeterol formulation patient asthma . In term safety comparison , repeat measurement adverse event , vital sign , heart rate , blood hematology biochemistry well ECG change enable establishment similar safety profile test reference Fluticasone/Salmeterol combination .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<criteria>age 1865 year , diagnosis asthma 6 month , FEV1 ≥ 50 % ≤ 80 % predict , reversibility least 12 % , stable asthma least 4 week , inhaled steroid ( ICS ) stable dose within previous 30 day , PIF 30 90 lt/min inform consent . history pulmonary disease , asthma exacerbation respiratory infection within previous 4 week , hospitalization acute asthmatic symptom require parenteral steroid oral steroid dose increase , within previous 30 day , heavy smoker , change asthma medication within previous 4 week , seasonal asthma alone , history severe heart disease , pregnancy lactation , use βblocker , NSAID antiallergic/antihistaminic medication within 2 week prior screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>